23andMe: Spit, Scandal, and a $6 Billion Meltdown with Kevin Sullivan and Laura Peek | 88
The Big Flop
00:00
23andMe: Navigating Ethics and Regulations
This chapter explores the ethical dilemmas faced by 23andMe as it grapples with reduced scientific staffing and FDA regulations on its genetic tests. Amidst efforts to grow its customer base and secure significant funding, the company experiences both financial struggles and unexpected successes. The narrative reveals the personal and professional challenges of its leadership as they navigate the turbulent landscape of health tech and consumer adoption.
Transcript
Play full episode
